メディシノバ・インク
Ticker 4875
No financial statements available
This company's filings don't include financial statements in a form we can read (common for foreign issuers), so there are no figures or ratios to show.
About this data
- Figures are consolidated when the company files consolidated statements, otherwise parent-only.
- A change of accounting standard starts a new series.
- Each fiscal year is labelled with the month it ends.
- A blank figure was not reported in the filing, or is not meaningful (e.g. free cash flow for banks); the reason is shown with it.
- Each year is shown as filed in that year's own report; restatements of past years in later reports are not applied. Year-over-year changes compare with the prior year as the current year's report restates it.
- Data as of Oct 30, 2026 (newest filing in our dataset).
Industry peers
Companies in Pharmaceutical with the highest ROE
- 4506 Sumitomo Pharma Co., Ltd. Return on equity46.3%
- 197A TAUNS Laboratories,Inc. Return on equity29.8%
- 4519 CHUGAI PHARMACEUTICAL CO., LTD. Return on equity22.1%
- 4570 Immuno-Biological Laboratories Co., Ltd. Return on equity19.6%
- 4595 MIZUHO MEDY CO.,LTD. Return on equity19.0%
- 4503 Astellas Pharma Inc. Return on equity17.4%
- 4568 DAIICHI SANKYO COMPANY, LIMITED Return on equity16.9%
- 4507 Shionogi & Co., Ltd. Return on equity13.5%